Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder

Neurology

Volumn 86, Issue 1, 2016, Pages 79-87

  Nour, Matthew M ^a   Nakashima, Ichiro ^b   Coutinho, Ester ^a   Woodhall, Mark ^a   Sousa, Filipa ^c   Revis, Jon ^a   Takai, Yoshiki ^b   George, Jithin ^a   Kitley, Joanna ^a   Santos, Maria Ernestina ^d   Nour, Joseph M ^a   Cheng, Fan ^a   Kuroda, Hiroshi ^b   Misu, Tatsuro ^b   Martins Da Silva, Ana ^d   Deluca, Gabriele C ^a   Vincent, Angela ^a   Palace, Jacqueline ^a   Waters, Patrick ^a   Fujihara, Kazuo ^b   Leite, Maria Isabel ^a   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HOSPITAL DE BRAGA   (Portugal)

^d HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; AQUAPORIN 4 ANTIBODY; AZATHIOPRINE; PREDNISOLONE; AQP4 PROTEIN, HUMAN; AUTOANTIBODY;

ADULT; ARTICLE; CONCEPTION; DISEASE ACTIVITY; FEMALE; HUMAN; HYDROCEPHALUS; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MATERNAL AGE; MENTAL DEFICIENCY; MYELOOPTIC NEUROPATHY; NEUROMYELITIS OPTICA SPECTRUM DISORDER; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; SPONTANEOUS ABORTION; ABORTION, SPONTANEOUS; BLOOD; COHORT ANALYSIS; INTERNATIONAL COOPERATION; NEUROMYELITIS OPTICA; PRE-ECLAMPSIA; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDY; RISK FACTOR;

ABORTION, SPONTANEOUS; ADULT; AQUAPORIN 4; AUTOANTIBODIES; COHORT STUDIES; FEMALE; HUMANS; INTERNATIONALITY; NEUROMYELITIS OPTICA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84952360960     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002208     Document Type: Article

References (39)

1. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 805-815
2. Yanagawa K, Kawachi I, Toyoshima Y, et al. Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis. Neurology 2009; 73: 1628-1637
3. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112
4. Quek AML, McKeon A, Lennon VA, et al. Effects of age and sex on aquaporin-4 autoimmunity. Arch Neurol 2012; 69: 1039-1043
5. Cornelio DB, Braga RP, Rosa MW, Ayub AC. Devics neuromyelitis optica and pregnancy: distinction from multiple sclerosis is essential. Arch Gynecol Obstet 2009; 280: 475-477
6. Bencherifa F, Bourissa A, Mellal Z, Berraho A. Devics neuro-optic myelitis and pregnancy. J Fr Ophtalmol 2007; 30: 737-743
7. Bonnet F, Mercié P, Morlat P, et al. Devics neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus. Lupus 1999; 8: 244-247
8. Reuss R, Rommer P, Bruck W, Paul F, Bolz M. A woman with acute myelopathy in pregnancy: case outcome. BMJ 2009; 339: 1372-1373
9. De Falco M, Cobellis L, Torella M, et al. Down-regulation of aquaporin 4 in human placenta throughout pregnancy. In Vivo 2007; 21: 813-817
10. Saadoun S, Waters P, Leite MI, Bennett JL, Vincent A, Papadopoulos MC. Neuromyelitis optica IgG causes placental inflammation and fetal death. J Immunol 2013; 191: 2999-3005
11. Bourre B, Marignier R, Zéphir H, et al. Neuromyelitis optica and pregnancy. Neurology 2012; 78: 875-879
12. Kim W, Kim SH, Nakashima I, et al. Influence of pregnancy on neuromyelitis optica spectrum disorder. Neurology 2012; 78: 1264-1267
13. Fragoso YD, Adoni T, Bichuetti DB, et al. Neuromyelitis optica and pregnancy. J Neurol 2013; 260: 2614-2619
14. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489
15. Waters PJ, McKeon A, Leite MI, et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 2012; 78: 665-671
16. Takahashi T, Fujihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007; 130: 1235-1243
17. Jurkovic D, Overton C, Bender-Atik R. Diagnosis and management of first trimester miscarriage. BMJ 2013; 346: f3676
18. Khalil A, Syngelaki A, Maiz N, Zinevich Y, Nicolaides KH. Maternal age and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol 2013; 42: 634-643
19. Regan L, Braude PR, Trembath PL. Influence of past reproductive performance on risk of spontaneous abortion. BMJ 1989; 299: 541-545
20. Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol 2012; 11: 535-544
21. Suzuki N, Takahashi T, Aoki M, et al. Neuromyelitis optica preceded by hyperCKemia episode. Neurology 2010; 74: 1543-1545
22. Guo Y, Lennon VA, Popescu BFG, et al. Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum. JAMA Neurol 2014; 71: 1025-1029
23. Ratelade J, Bennett JL, Verkman AS. Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema. PLoS One 2011; 6: e27412
24. Leite M, Coutinho E, Lana-Peixoto M. Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology 2012; 78: 1601-1607
25. Nishiyama S, Ito T, Misu T, et al. A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology 2009; 72: 1960-1961
26. Amato MP, Portaccio E, Ghezzi A, et al. Pregnancy and fetal outcomes after interferon-b exposure in multiple sclerosis. Neurology 2010; 75: 1794-1802
27. Sandberg-Wollheim M, Alteri E, Moraga MS, Kornmann G. Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy. Mult Scler 2011; 17: 423-430
28. Smyth A, Oliveira GHM, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and metaanalysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 2010; 5: 2060-2068
29. Kitley J, Leite MI, Nakashima I, et al. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain 2012; 135: 1834-1849
30. Ostensen M, Brucato A, Carp H, et al. Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology 2011; 50: 657-664
31. Norwood F, Dhanjal M, Hill M, et al. Myasthenia in pregnancy: best practice guidelines from a UK multispecialty working group. J Neurol Neurosurg Psychiatry 2014; 85: 538-543
32. Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens 2008; 21: 521-526
33. Klungsøyr K, Morken NH, Irgens L, Vollset SE, Skjaerven R. Secular trends in the epidemiology of preeclampsia throughout 40 years in Norway: prevalence, risk factors and perinatal survival. Paediatr Perinat Epidemiol 2012; 26: 190-198
34. Gordon C. Pregnancy and autoimmune diseases. Best Pract Res Clin Rheumatol 2004; 18: 359-379
35. Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006; 54: 899-907
36. Barnado A, Wheless L, Meyer AK, Gilkeson GS, Kamen DL. Pregnancy outcomes among African-American patients with systemic lupus erythematosus compared with controls. Lupus Sci Med 2014; 1: e000020
37. Gömöri E, Pál J, Abrahám H, et al. Fetal development of membrane water channel proteins aquaporin-1 and aquaporin-4 in the human brain. Int J Dev Neurosci 2006; 24: 295-305
38. Owler B, Pitham T, Dongwei W. Aquaporins: relevance to cerebrospinal fluid physiology and therapeutic potential in hydrocephalus. Cerebrospinal Fluid Res 2010; 7: 15
39. Clardy SL, Lucchinetti CF, Krecke KN, et al. Hydrocephalus in neuromyelitis optica. Neurology 2014; 82: 1841-1843